Prexasertib
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Prexasertib, covering 2017-05-22 to 2025-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma [Phase 1, Phase 2]